Effectiveness and cost-effectiveness of imatinib for first-line treatment of chronic myeloid leukaemia in chronic phase: a systematic review and economic analysis

Effectiveness and cost-effectiveness of imatinib for first-line treatment of chronic myeloid leukaemia in chronic phase: a systematic review and economic analysis

Bibliographic Details
Main Authors:	K Dalziel, A Round, K Stein, R Garside, A Price
Format:	Article
Language:	English
Published:	NIHR Journals Library 2004-07-01
Series:	Health Technology Assessment
Online Access:	https://doi.org/10.3310/hta8280

Similar Items

The effectiveness and cost-effectiveness of imatinib in chronic myeloid leukaemia: a systematic review
by: R. Garside, et al.
Published: (2002-01-01)

Dasatinib, nilotinib and standard-dose imatinib for the first-line treatment of chronic myeloid leukaemia: systematic reviews and economic analyses.
by: T Pavey, et al.
Published: (2012-11-01)

Molecular mechanisms of imatinib resistance in chronic myeloid leukaemia
by: Wang, Lihui
Published: (2011)

Predictors of imatinib response in patients with chronic myeloid leukaemia
by: Crossman, Lucy C.
Published: (2006)

Bisphosphonates in the treatment of Imatinib-resistant chronic myeloid leukaemia
by: Chuah, Charles Thuan Heng
Published: (2006)

Dasatinib and nilotinib for imatinib-resistant or -intolerant chronic myeloid leukaemia: a systematic review and economic evaluation.
by: G Rogers, et al.
Published: (2012-04-01)

Evolution of treatment response to IMATINIB in patients diagnosed with chronic myeloid leukaemia
by: Mendes, Alexandrina Maria da Silva
Published: (2011)

Dasatinib, high-dose imatinib and nilotinib for the treatment of imatinib-resistant chronic myeloid leukaemia: a systematic review and economic evaluation.
by: E Loveman, et al.
Published: (2012-05-01)

Modelling Predictors of Molecular Response to Frontline Imatinib for Patients with Chronic Myeloid Leukaemia.
by: Haneen Banjar, et al.
Published: (2017-01-01)

First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib
by: Rafiyath Shamudheen, et al.
Published: (2010-11-01)

Hyperpigmentation of the hard palate mucosa in a patient with chronic myeloid leukaemia taking imatinib
by: Gian Paolo Bombeccari, et al.
Published: (2017-12-01)

Intravitreal Bevacizumab and Triamcinolone for Treatment of Cystoid Macular Oedema Associated with Chronic Myeloid Leukaemia and Imatinib Therapy
by: Eric K. Newcott, et al.
Published: (2015-01-01)

Azacitidine for the treatment of myelodysplastic syndrome, chronic myelomonocytic leukaemia and acute myeloid leukaemia
by: R Edlin, et al.
Published: (2010-05-01)

Cost effectiveness of therapeutic drug monitoring for imatinib administration in chronic myeloid leukemia.
by: Kibum Kim, et al.
Published: (2019-01-01)

Molecular response to imatinib & its correlation with mRNA expression levels of imatinib influx & efflux transporters in patients with chronic myeloid leukaemia in chronic phase
by: Hemant Malhotra, et al.
Published: (2015-01-01)

The clinical effectiveness and cost-effectiveness of rituximab for the first-line treatment of chronic lymphocytic leukaemia: an evidence review of the submission from Roche
by: C Main, et al.
Published: (2010-10-01)

IMPACT OF IMATINIB MESYLATE ON SLC22A1 GENE EXPRESSION IN CHRONIC MYELOID LEUKAEMIA CELL LINE, K562
by: Sreenivasan, Sandhya
Published: (2013)

Prescribing pattern of imatinib among chronic phase chronic myeloid leukaemia (CML) patients and its financial impact on Hong Kong
by: Cheng, Man-ying, et al.
Published: (2014)

IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
by: Tomasz Sacha
Published: (2013-12-01)

Evaluation of the Relationship Between Initial Lymphocyte Count and Molecular Response to Imatinib Therapy in Chronic Myeloid Leukaemia Patients
by: İstemi Serin, et al.
Published: (2020-11-01)

Carboxyamidotriazole-orotate inhibits the growth of imatinib-resistant chronic myeloid leukaemia cells and modulates exosomes-stimulated angiogenesis.
by: Chiara Corrado, et al.
Published: (2012-01-01)

Imatinib en leucemia mieloide crónica Imatinib in chronic myeloid leukemia
by: Valia Pavón Morán, et al.
Published: (2005-12-01)

Dasatinib treatment of imatinib-resistant and imatinib-intolerant patients with chronic myeloid leukemia in a chronic phase
by: Ol'ga Yur'evna Vinogradova, et al.
Published: (2009-07-01)

Targets for therapy of chronic myeloid leukaemia
by: Cwynarski, Katherine Louise
Published: (2004)

T-cell responses in chronic myeloid leukaemia
by: Abu-Eisha, Hazem Mahmoud
Published: (2005)

Telomere dynamics in chronic myeloid leukaemia
by: Gil, Marcel Eduardo
Published: (2014)

Cytogenic studies in chronic myeloid and chronic lymphocytic leukaemias
by: Pearson, J.
Published: (1983)

Retraction: Carboxyamidotriazole-Orotate Inhibits the Growth of Imatinib-Resistant Chronic Myeloid Leukaemia Cells and Modulates Exosomes-Stimulated Angiogenesis.
by: PLOS ONE Editors
Published: (2019-01-01)

Dasatinib in the treatment of imatinib refractory chronic myeloid leukemia
by: Radhakrishnan Ramchandren, et al.
Published: (2009-05-01)

Effect of Imatinib on Bone Marrow Morphology and Angiogenesis in Chronic Myeloid Leukemia
by: Neetu Pandey, et al.
Published: (2019-01-01)

Treatment efficacy of chronic myeloid leukemia with imatinib in clinical practice
by: A. K. Golenkov, et al.
Published: (2014-07-01)

Treatment efficacy of chronic myeloid leukemia with imatinib in clinical practice
by: A. K. Golenkov, et al.
Published: (2014-07-01)

Mutation status of refractory to imatinib patients with chronic myeloid leukemia
by: E. G. Ovsyannikova, et al.
Published: (2014-07-01)

Mutation status of refractory to imatinib patients with chronic myeloid leukemia
by: E. G. Ovsyannikova, et al.
Published: (2014-07-01)

Fludarabine phosphate for the first-line treatment of chronic lymphocytic leukaemia
by: S Walker, et al.
Published: (2009-06-01)

Cumulative clinical experience from a decade of use: imatinib as first-line treatment of chronic myeloid leukemia
by: Baran Y, et al.
Published: (2012-11-01)

Response to imatinib mesylate in childhood chronic myeloid leukemia in chronic phase
by: Vijay Gandhi Linga, et al.
Published: (2014-01-01)

The effectiveness and cost-effectiveness of microwave and thermal balloon endometrial ablation for heavy menstrual bleeding: a systematic review and economic modelling
by: R Garside, et al.
Published: (2004-02-01)

Monitoring imatinib plasma concentrations in chronic myeloid leukemia
by: Darlize Hübner Martins, et al.
Published: (2011-01-01)

Targeted treatment of chronic myeloid leukemia: role of imatinib
by: Ila Tamascar, et al.
Published: (2009-03-01)